First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer - John V. Heymach; Noboru Yamamoto; Nicolas Girard; Gerrina Ruiter; Egbert F. Smit; David Planchard; Ernest Nadal; Yi-Long Wu; Jon Zugazagoitia; Hai-Yan Tu; Christina S. Baik; Kiyotaka Yoh; et al. (New England Journal of Medicine, 2026)